Functional Skills
Market Research
Primary Research
Data Modeling
Financial Modeling
Market Access Strategy
Portfolio Optimization
Qualitative Research
Reimbursement Strategy
Revenue Cycle Optimization
Strategic Planning
Software Skills
Microsoft Access
Microsoft Excel
Microsoft Office
Microsoft PowerPoint
Microsoft Word
Certifications
FHMFAFellow of the Healthcare Financial Management Association
Sector Experience
Business Services
Healthcare
Life Sciences & Pharma
Experience
Vynamic
Marketing
US Oncology Portfolio Brand Planning and Portfolio Prioritization Consultant
2/2022 - Present
-Manage the organization's oncology Tumor Prioritization process by coordinating with marketing stakeholders (i.e., Finance, data & analytics, Forecasting, etc.) and cross-functional team members to support the generation of outputs and socialization materials
-Assist in the evolution of the financial model based on business needs and market challenges to drive prioritization of pipeline assets to optimize allocation of resources and investments appropriately
-Provide guidance to marketing brand teams for strategic and tactical business planning including development and execution of a detailed timelines, communication plans, and tailoring of materials/templates to support the annual planning cycle
-Developed the annual investment story for US Oncology for senior leadership; acted as a liaison between leadership and marketing stakeholders during tradeoff discussions for investment/resource allocation
-Assist in the evolution of the financial model based on business needs and market challenges to drive prioritization of pipeline assets to optimize allocation of resources and investments appropriately
-Provide guidance to marketing brand teams for strategic and tactical business planning including development and execution of a detailed timelines, communication plans, and tailoring of materials/templates to support the annual planning cycle
-Developed the annual investment story for US Oncology for senior leadership; acted as a liaison between leadership and marketing stakeholders during tradeoff discussions for investment/resource allocation
Clarivate (fka Decision Resources Group)
Product Management / Strategy
Project Manager & Market Access Consultant
9/2021 - 1/2022
Market access consultant duties: Completed 20+ KOL interviews (moderator & transcriber) with payers (i.e., PBMs, IDNs, and MCOs); performed qualitative and quantitative analysis via Qualtrics surveys; and created client decks.
Boost HealthCare Consultant
Other
Senior Consultant & Project Lead
10/2019 - 10/2021
• Utilize data management tools to evaluate hospital financial systems and operations to identify areas of risk within revenue cycles
• Collaborate with client Marshfield Clinic Health System C-level executives to improve provider revenue performance by evaluating payer contracting and reimbursement negotiations and strategies
• Contributed 49% toward a team revenue recovery goal of $150,000 in Q1 2020 and 58% toward team recovery goal of $400,000
• Collaborate with client Marshfield Clinic Health System C-level executives to improve provider revenue performance by evaluating payer contracting and reimbursement negotiations and strategies
• Contributed 49% toward a team revenue recovery goal of $150,000 in Q1 2020 and 58% toward team recovery goal of $400,000
Acsel Health
Product Management / Strategy
Market Access Consultant
10/2020 - 12/2020
Primary market access consultant duties: performed extensive market research on pharma manufacturer copay cards for specific therapeutic areas (i.e., rheumatology, neurology, dermatology, and ophthalmology) and created client decks/deliverables.
KX Advisors
Corporate Strategy & Development
Competitive Intelligence Consultant
9/2020 - 10/2020
Performed competitive intelligence in the diagnostic space for a large biotech company. Consultant duties include: KOL interview moderator & transcriber, financial analyses (revenue projections, market share, etc.), organizational analysis, client decks/deliverables, and interim/final readouts.
Hologic
Corporate Strategy & Development
Strategy & Business Development
9/2018 - 5/2019
• Confirmed significant unmet need in women’s health pertaining to endometriosis by exploring
potential biomarkers and establishing relevance of Hologic-owned technologies
• Evaluated new pipeline therapies that yield expanded opportunity by validating Hologic U.S.
OB/GYN channel aids in developing market and altering standard of care
potential biomarkers and establishing relevance of Hologic-owned technologies
• Evaluated new pipeline therapies that yield expanded opportunity by validating Hologic U.S.
OB/GYN channel aids in developing market and altering standard of care
Poseidon Laboratory
Marketing
Market Research & Competitive Intelligence
9/2018 - 12/2018
• Examined the market landscape surrounding potential use cases for Poseidon’s technology,
and investigate the marketplace surrounding existing indications being served by monoclonal
antibodies
• Estimated the addressable market for a potential product launch by Poseidon, and identify
potential partnering opportunities for Poseidon within prioritized markets
and investigate the marketplace surrounding existing indications being served by monoclonal
antibodies
• Estimated the addressable market for a potential product launch by Poseidon, and identify
potential partnering opportunities for Poseidon within prioritized markets
BioCentury Publications
Data Science / Analytics
Business Intelligence
10/2018 - 12/2018
• Executed quality control through data analysis by prescreening press releases and SEC earnings report from biotech and pharmaceutical companies
• Evaluated pipeline, deals, and market data of biotech/biopharma companies using BioCentury BCIQ database
• Evaluated pipeline, deals, and market data of biotech/biopharma companies using BioCentury BCIQ database
BioMarin Pharmaceuticals
Corporate Strategy & Development
Business Development
6/2018 - 8/2018
Performed a precedent transaction analysis of biopharma companies with suitable and lucrative pipelines in preparation for negotiations
• Conducted interviews with Key Opinion Leaders in healthcare to identify commercially viable rare diseases
• Communicated with directors of different departments to compile internal information onto a shared data room for potential deals with external companies
• Conducted interviews with Key Opinion Leaders in healthcare to identify commercially viable rare diseases
• Communicated with directors of different departments to compile internal information onto a shared data room for potential deals with external companies